Press Releases

Date	Title	Company
11-Dec-2023	Global Microplate Instrumentation and Systems Industry is forecasted to grow steadily at a 4.9% CAGR between 2023 and 2033 \| FMI	MARKITWIRED
11-Dec-2023	Global Viral Vector Development Industry is projected to achieve an impressive US$ 4.1 Billion by 2033, majorly influenced by innovations in gene therapy solutions \| FMI	MARKITWIRED
11-Dec-2023	Global Veterinary Disinfectants for Pets and Farms Industry could reach a valuation exceeding US$ 7.3 Billion by 2033	MARKITWIRED
11-Dec-2023	Global Heart Beat Irregularity Detection Device Industry is slated to achieve a 4.5% CAGR, reaching a valuation of US$ 20.7 Million by 2033	MARKITWIRED
11-Dec-2023	Global Clinical Nutrition Industry might surge to an impressive valuation of US$ 29.2 Billion by 2033, signifying a seismic shift in healthcare methodologies \| FMI	MARKITWIRED
11-Dec-2023	Global Hernia Repair Devices Industry could potentially reach a valuation surpassing US$ 12.3 Billion by 2033 as projected by FMI	MARKITWIRED
11-Dec-2023	Osteoarthritis Therapeutics Market Sets New Record, Projected at USD 15.69 Billion By 2030 at 8.8% CAGR	The Wire Times
11-Dec-2023	Long Read Sequencing Market Sets New Record, Projected at USD 4.5 Billion by 2031 at 22.3% CAGR	The Wire Times
11-Dec-2023	New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma	Businesswire
11-Dec-2023	ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma	Businesswire
11-Dec-2023	MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study	MorphoSys AG
10-Dec-2023	Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B	Businesswire
10-Dec-2023	Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting	Businesswire
10-Dec-2023	GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	Businesswire
10-Dec-2023	Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023	Businesswire
10-Dec-2023	Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting	Businesswire
10-Dec-2023	Bristol Myers Squibb Presents Primary Efficacy and Safety Analysis of the Phase 3 COMMANDS Trial of Reblozyl for Treatment of Anemia in Erythropoiesis Stimulating Agent-Naïve Patients with Lower-Risk Myelodysplastic Syndromes at ASH 2023	Businesswire
09-Dec-2023	New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)	Businesswire
09-Dec-2023	Rallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual Meeting	Businesswire
09-Dec-2023	New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A	Businesswire